Development of Neuroinflammatory Cytokines and Amyloid‐β Production in Alzheimer's Disease

These findings support the potential use of blood-based biomarkers for the early detection and monitoring of AD. The study highlights the significance of targeting neuroinflammatory pathways as a potential therapeutic strategy to mitigate Aβ accumulation and slow disease progression. A deeper understanding of the molecular interactions between inflammatory cytokines and Aβ could open new therapeutic avenues for AD intervention.